This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

The secret life of CD4+ T cells: From helpers to melanoma fighters

The secret life of CD4+ T cells: from helpers to melanoma fighters
CD4+ T cells (green) attacking melanoma cells (red) in the skin. Credit: Dr. Bawden / Doherty Institute

A study led by the Peter Doherty Institute for Infection and Immunity (Doherty Institute) has found that CD4+ T cells, traditionally called 'helper T cells' for their role in aiding the activation of other immune cells, are remarkably effective in controlling melanoma.

University of Melbourne's Dr. Emma Bawden, Postdoctoral Researcher at the Doherty Institute and lead author of the study, said this discovery challenges the conventional understanding of the role of CD4+ T cells in cancer immunity. The work is published in Science Immunology.

"Our in-depth study, using animal models, unraveled the complex biology of CD4+ T cells in melanoma and how they control cancer," explained Dr. Bawden.

"Using microscopic live imaging, we visualized the activities and interactions of CD4+ T cells with other in the tumor microenvironment. Our findings challenge previous assumptions by showing that CD4+ T cells can combat tumors through a multitude of pathways."

The detailed analysis revealed the , developmental states and functions of CD4+ T cells in melanoma, showing the potential of harnessing CD4+ T cells for future therapies against the skin cancer.

University of Melbourne Professor Thomas Gebhardt, Senior Research Fellow at the Doherty Institute and senior author of the study, said that understanding CD4+ T cell responses could pave the way for more effective immunotherapies against melanoma.

CD4+ T cells (green) attacking melanoma cells (red) in the skin. Credit: Dr. Bawden / Doherty Institute

"While CD4+ T cells are often viewed as accessory cells regulating the function of other immune cells, our work shows they can work effectively on their own. Therefore, harnessing their potential therapeutically holds great promise for the development and improvement of current cancer immunotherapies," said Professor Gebhardt.

More than 15,000 Australians are diagnosed with melanoma every year, a rare but highly aggressive form of .

More information: Emma Bawden et al, CD4+ T cell immunity against cutaneous melanoma encompasses multifaceted MHC II-dependent responses, Science Immunology (2024). DOI: 10.1126/sciimmunol.adi9517. www.science.org/doi/10.1126/sciimmunol.adi9517

Journal information: Science Immunology
Citation: The secret life of CD4+ T cells: From helpers to melanoma fighters (2024, January 19) retrieved 29 May 2024 from https://medicalxpress.com/news/2024-01-secret-life-cd4-cells-helpers.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Immune cell helps predict skin cancer patients' chances of responding to treatment

49 shares

Feedback to editors